Inhibition of conditioned avoidance response by a new neuroleptic (LR 511). Interference with drugs endowed with different CNS activity.
D000818:Animals; D014150:Antipsychotic Agents / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D001362:Avoidance Learning / Q000187:drug effects*; D002746:Chlorpromazine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D005260:Female; D006220:Haloperidol / Q000494:pharmacology; D010080:Oxazoles / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D010879:Piperazines / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D011619:Psychotropic Drugs / Q000494:pharmacology*; D051381:Rats
D014150:Antipsychotic Agents; D010080:Oxazoles; D010879:Piperazines; D011619:Psychotropic Drugs; C015599:LR 511; D006220:Haloperidol; D002746:Chlorpromazine